University of Cologne | MedPath Search

Clinical Trials

Find the latest clinical trials by condition, location & phase

Browse and search for drug information and related clinical trials

Explore a comprehensive list of organizations, including their profiles and details.

Latest updates on clinical trials, pharmaceuticals, and healthcare companies

DeepMed Research

|

Filters

Study Phase

Early Phase 1

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

Phase 4

Not Applicable

Recruitment Status

Recruiting

Not yet recruiting

Active, not recruiting

Completed

Suspended

Terminated

Withdrawn

Study Type

Interventional

Observational

Expanded Access

Others

Eligibility Sex

All

Female

Male

Healthy Volunteers

All

Include

Exclude

Found 407 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "University of Cologne"?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

Immun Response in Children With MIS-C

Conditions: MIS-C Multisystem Inflammatory Syndrome in Children

Interventions: Diagnostic Test: Analysis of cytokines and immun cell related markers

First Posted Date: 2021-09-22

Last Posted Date: 2021-09-22

Lead Sponsor: University of Cologne

Target Recruit Count: 20

Registration Number: NCT05052424

Locations: 🇩🇪
University of Cologne, Medical Faculty, Cologne, Germany

A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma

Phase 3

Recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Selinexor
Drug: Elotuzumab
Drug: Pomalidomide
Drug: Dexamethasone Oral

First Posted Date: 2021-08-31

Last Posted Date: 2024-10-26

Lead Sponsor: Stichting European Myeloma Network

Target Recruit Count: 222

Registration Number: NCT05028348

Locations: 🇺🇸
The University of Arizona Cancer Center, Tucson, Arizona, United States
🇺🇸
California Cancer Associates for Research and Excellence, Encinitas, California, United States
🇺🇸
University of California, San Francisco, Fresno, California, United States

and more 91 locations

Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP

Recruiting

Conditions: Acquired Thrombotic Thrombocytopenic Purpura

Interventions: Drug: Cablivi®

First Posted Date: 2021-08-02

Last Posted Date: 2024-12-09

Lead Sponsor: University of Cologne

Target Recruit Count: 350

Registration Number: NCT04985318

Locations: 🇩🇪
University Hospital of Cologne, Cologne, Germany

Benefit of Expanded Surveillance of Nursing Homes During the COVID-19 Pandemic

Completed

Conditions: COVID-19 Respiratory Infection
SARS-CoV-2 Infection

Interventions: Diagnostic Test: Nasopharyngeal swab for SARS-CoV-2

First Posted Date: 2021-06-22

Last Posted Date: 2024-04-08

Lead Sponsor: University of Cologne

Target Recruit Count: 1587

Registration Number: NCT04933981

Locations: 🇩🇪
University Hospital Cologne, Cologne, NRW, Germany

Shock Testing to Unmask RV Lead and GEnerator Malfunction in ICD Patients: the SURGE-ICD Registry

Recruiting

Conditions: Implantable Defibrillator Lead Dysfunction
Implantable Automatic Defibrillator Malfunction
Implantable Defibrillator User

First Posted Date: 2021-04-26

Last Posted Date: 2022-06-02

Lead Sponsor: Universitätsklinikum Köln

Target Recruit Count: 300

Registration Number: NCT04858672

Locations: 🇩🇪
Department of electrophysiology, Heart Center Cologne, University of Cologne, Cologne, NRW, Germany

HIgh Power Short Duration Radiofrequency Ablation or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation

Not Applicable

Conditions: Atrial Fibrillation and Flutter
Paroxysmal Atrial Fibrillation
Atrial Fibrillation

Interventions: Procedure: Ablation

First Posted Date: 2021-04-22

Last Posted Date: 2021-07-26

Lead Sponsor: Universitätsklinikum Köln

Target Recruit Count: 170

Registration Number: NCT04855890

Locations: 🇩🇪
Department of electrophysiology, Heart Center Cologne, University of Cologne, Cologne, NRW, Germany

Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma

Phase 2

Recruiting

Conditions: Classical Hodgkin Lymphoma

Interventions: Drug: Pembrolizumab plus Chemotherapy (ICE or DHAP)

First Posted Date: 2021-04-09

Last Posted Date: 2024-08-23

Lead Sponsor: University of Cologne

Target Recruit Count: 29

Registration Number: NCT04838652

Locations: 🇩🇪
1st Department of Medicine, Cologne University Hospital, Cologne, Germany

Phase II Trial of Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma

Phase 2

Recruiting

Conditions: Classical Hodgkin Lymphoma

Interventions: Drug: Tislelizumab

First Posted Date: 2021-04-08

Last Posted Date: 2024-07-26

Lead Sponsor: University of Cologne

Target Recruit Count: 120

Registration Number: NCT04837859

Locations: 🇩🇪
1st Department of Medicine, Cologne University Hospital, Cologne, Germany

Prediction of Outcomes After Surgery for Unruptured Intracranial Aneurysms

Conditions: Aneurysm, Brain

Interventions: Procedure: Microsurgery

First Posted Date: 2021-03-26

Last Posted Date: 2021-12-21

Lead Sponsor: University of Zurich

Target Recruit Count: 4000

Registration Number: NCT04819074

Locations: 🇨🇭
University Hospital Zurich, Zürich, Switzerland
🇨🇭
Inselspital Bern, Bern, Switzerland
🇺🇸
UCLA, Los Angeles, California, United States

and more 34 locations

Kidney in Coronavirus Disease 2019 Registry

Recruiting

Conditions: SARS-CoV 2
Corona Virus Infection

Interventions: Other: Retrospective data collection

First Posted Date: 2021-03-15

Last Posted Date: 2024-05-08

Lead Sponsor: University of Cologne

Target Recruit Count: 500

Registration Number: NCT04797091

Locations: 🇩🇪
University Hospital of Cologne, Cologne, Germany

Prev
1
5
6
7
8
9
41
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy